Total trials
151
Active
39
Phase 3
1
Total enrollment
24,566
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Reboxetine Pill | — | — | — | — | — | 1 | |
| Methylphenidate Oral Product | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
Top conditions
- Stroke20
- Healthy10
- Mental Fatigue10
- Fibromyalgia4
- Chronic Low-back Pain4
- Fatigue4
- Lower Limb Amputation Above Knee (Injury)4
- Sarcopenia4
Frequently asked questions about Vrije Universiteit Brussel
- How many clinical trials does Vrije Universiteit Brussel have on ClinicalTrials.gov?
- Vrije Universiteit Brussel is listed as the lead sponsor on 151 clinical trials in ClinicalTrials.gov, 39 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Vrije Universiteit Brussel's trials are in Phase 3?
- 1 of Vrije Universiteit Brussel's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Vrije Universiteit Brussel focus on?
- Vrije Universiteit Brussel's most-studied conditions on ClinicalTrials.gov are Stroke, Healthy, Mental Fatigue, Fibromyalgia, Chronic Low-back Pain.
- When are Vrije Universiteit Brussel's next clinical trial readouts?
- Vrije Universiteit Brussel has 1 upcoming primary-completion readout tracked here; the soonest is “The Role of the Brain in Mental and Physical Fatigue”, expected around 2025-12-31.